Omada Health OMDA 深 沪
等待开盘 10-09 09:30:00 美东时间
23.98
+0.680
+2.92%
华盛通- 最 高25.28
- 今 开23.61
- 成交量 94.12万股
- 最 低 23.50
- 昨 收 23.30
- 总市值 13.81亿
- 52周最高 28.40
- 市盈率 静 --
- 换手率 1.63%
- 52周最低 14.14
- 委 比 11.99%
- 总股本 5757.49万
- 历史最高 28.40
- 量 比 2.50
- 振 幅 7.64%
- 历史最低 14.14
- 每 手 1
- 风险率 2.62%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Omada Health Launches “Meal Map,” an AI-Powered Nutrition Experience Focused on Nutrient Quality, Not Calorie Counting
Omada Health has introduced Meal Map, a nutrient-categorization tool combining AI and human care teams to help members in cardiometabolic programs make informed food choices. Designed within Omada’s Nutritional Intelligence, Meal Map focuses on nutrient density rather than categorizing foods as "good" or "bad," aiming to foster confidence and sustainable healthy habits. Early results from a pilot program with over 1,000 members showed increased e...
10-01 13:00
杏石医疗大模型登 Nature 新闻版！方舟健客AI慢病管理模式获全球关注
中国医疗大模型，登上国际顶刊新闻版面！ 近日，Nature的新闻版面刊登了一则关于中国医疗大模型的报道，引发行业广泛关注。作为世界上创刊最早、影响力最高的国际性...
09-25 08:04
Getting Remote Right: Akamai-i4cp Survey Finds 83% of Remote-Friendly Companies Report High Productivity
Survey reveals talent, trust, and connection — not badge swipes — fuel success among remote-first companies CAMBRIDGE, Mass., Sept. 24, 2025 /PRNewswire/ -- Think productivity requires a ret...
09-24 21:02
New Omada Health Analysis Shows Long-Term Weight Maintenance Post-GLP-1 Discontinuation, Challenging Industry Assumptions
Omada Health's analysis shows that 63% of members maintained or continued to lose weight 12 months after discontinuing GLP-1s, with an average weight change of just 0.8%. This contrasts with typical 11-12% weight gain seen in clinical trials, highlighting the impact of continued lifestyle support. The study emphasizes the importance of sustained support for weight maintenance post-GLP-1 treatment, offering insights for employers managing rising G...
09-08 13:00
Baird Initiates Coverage On Omada Health with Neutral Rating, Announces Price Target of $24
Baird analyst Vikram Kesavabhotla initiates coverage on Omada Health (NASDAQ:OMDA) with a Neutral rating and announces Price Target of $24.
09-05 19:13
New Research from Omada Health Demonstrates Significant Cost Savings of Virtual Physical Therapy
Omada Health released a study showing that virtual physical therapy (V-PT) for musculoskeletal conditions resulted in lower healthcare costs and utilization compared to in-person PT, even when factoring in program costs. The research, using claims data from 2019 to 2023, found $100+ monthly savings per member and a positive ROI of 1.8x within six months. Virtual PT overcomes barriers like geographic access and high costs, offering a cost-effectiv...
08-28 13:00
Omada Health to Participate in Upcoming Investor Conference
Omada Health announced that senior management will participate in Morgan Stanley's 23rd Annual Global Healthcare Conference in New York on September 9, 2025. They will hold a fireside chat at 5:35 pm ET, with a live webcast and replay available at investors.omadahealth.com. As a virtual-first healthcare provider, Omada helps improve health outcomes for those with chronic conditions like diabetes and hypertension, with over a decade of experience ...
08-26 13:00
经历“数年禁令”后，科技公司IPO热潮汹涌 —— 或许好得过头了
核心要点 本周 Bullish 的 IPO 是华尔街再次对新科技公司上市表现出热情的最新迹象。 在 Bullish 股价上涨 84% 之前，Fig...
08-16 23:35
美股大行评级 | 潜在涨幅286.44%！RBC Capital上调Edgewise Therapeutics目标价至49美元，维持"跑赢大市"评级
今日重点评级关注：RBC Capital：维持Edgewise Therapeutics"跑赢大市"评级，目标价从48美元升至49美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从6美元升至7美元
08-11 09:43
Needham Maintains Buy on Omada Health, Raises Price Target to $24
Needham analyst Ryan MacDonald maintains Omada Health (NASDAQ:OMDA) with a Buy and raises the price target from $23 to $24.
08-08 17:57
